B&L buys Pharmos piece; deal could hit $49 million

November 17, 0001

B&L buys Pharmos piece; deal could hit $49 millionRochester, NY-Bausch & Lomb has acquired the rights to theloteprednol etabonate ophthalmic business of Pharmos Corp. for a price thatmight reach $49 million.